Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update

Go back to Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
(NASDAQ: FULC) Delayed: 3.85 +0.08 (2.12%)
Previous Close $3.77    52 Week High
Open $3.69    52 Week Low
Day High $3.89    P/E N/A 
Day Low $3.69    EPS
Volume 2,813,605